Warner & Kaine Applaud $35 Monthly Insulin Caps by Largest Insulin Manufacturers Following Inflation Reduction Act Implementation
January 03, 2024
January 03, 2024
WASHINGTON, Jan. 3 -- Sen. Tim Kaine, D-Virginia, issued the following news release on Jan. 2, 2024:
Today, U.S. Senators Mark R. Warner and Tim Kaine--who serves on the Senate Health, Education, Labor and Pensions Committee--released the following statements applauding Eli Lilly, Novo Nordisk, and Sanofi for officially lowering the cost of their insulin products to $35 per month for most patients. The companies' moves, which came in 2023 for Eli Lilly and January 1, 2024 for N . . .
Today, U.S. Senators Mark R. Warner and Tim Kaine--who serves on the Senate Health, Education, Labor and Pensions Committee--released the following statements applauding Eli Lilly, Novo Nordisk, and Sanofi for officially lowering the cost of their insulin products to $35 per month for most patients. The companies' moves, which came in 2023 for Eli Lilly and January 1, 2024 for N . . .